During the past decade, Robert Veith MD LLC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 16 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 15 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Robert Veith MD LLC" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Robert Veith MD LLC" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "Recurrent Breast Carcinoma" (2 trials) and "Stage IV Squamous Cell Lung Carcinoma" (2 trials). Many other conditions were trialed in "Robert Veith MD LLC" in a lesser frequency.

Most popular intervention types in "Robert Veith MD LLC" are "Other" (20 trials), "Drug" (18 trials), "Biological" (11 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Docetaxel" (6 trials), "Bevacizumab" (3 trials), "Durvalumab" (3 trials) and "FGFR Inhibitor AZD4547" (3 trials). Other intervention names were less common.

The vast majority of trials in "Robert Veith MD LLC" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Robert Veith MD LLC". undefined are not yet recruiting, undefined are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Robert Veith MD LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Robert Veith MD LLC, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".